Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2018 / Article

Review Article | Open Access

Volume 2018 |Article ID 8238459 | https://doi.org/10.1155/2018/8238459

Jeffrey A. Stuart, Joao Fonseca, Fereshteh Moradi, Cassandra Cunningham, Bishoy Seliman, Cydney R. Worsfold, Sarah Dolan, John Abando, Lucas A. Maddalena, "How Supraphysiological Oxygen Levels in Standard Cell Culture Affect Oxygen-Consuming Reactions", Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 8238459, 13 pages, 2018. https://doi.org/10.1155/2018/8238459

How Supraphysiological Oxygen Levels in Standard Cell Culture Affect Oxygen-Consuming Reactions

Academic Editor: Eric E. Kelley
Received03 May 2018
Accepted01 Aug 2018
Published30 Sep 2018

Abstract

Most mammalian tissue cells experience oxygen partial pressures in vivo equivalent to 1–6% O2 (i.e., physioxia). In standard cell culture, however, headspace O2 levels are usually not actively regulated and under these conditions are ~18%. This drives hyperoxia in cell culture media that can affect a wide variety of cellular activities and may compromise the ability of in vitro models to reproduce in vivo biology. Here, we review and discuss some specific O2-consuming organelles and enzymes, including mitochondria, NADPH oxidases, the transplasma membrane redox system, nitric oxide synthases, xanthine oxidase, and monoamine oxidase with respect to their sensitivities to O2 levels. Many of these produce reactive oxygen and/or nitrogen species (ROS/RNS) as either primary end products or byproducts and are acutely sensitive to O2 levels in the range from 1% to 18%. Interestingly, many of them are also transcriptional targets of hypoxia-inducible factors (HIFs) and chronic cell growth at physioxia versus 18% O2 may alter their expression. Aquaporins, which facilitate hydrogen peroxide diffusion into and out of cells, are also regulated by HIFs, indicating that O2 levels may affect intercellular communication via hydrogen peroxide. The O2 sensitivities of these important activities emphasize the importance of maintaining physioxia in culture.

1. Introduction

Mammalian cells are typically cultured under hyperoxic conditions. While most cells experience oxygen levels of 1–6% in vivo (physioxia; Table 1), almost all mammalian cell culture is done in humidified atmospheric air at 37°C with CO2 added to 5%. Although the headspace O2 level is usually not measured, it is 18-19% under these conditions due to displacement of O2 by water vapour and CO2. When O2 levels used in cell culture experiments are measured and reported, these are virtually always those of headspace gas and not media. Particularly in metabolically active cells growing in high density, the pericellular media O2 levels that cells experience may be substantially lower than headspace O2 levels [13], since O2 is continually removed from media by mitochondrial respiration and by other O2-consuming cellular activities.


Tissue/compartmentpO2 (%)Reference

Brain4.4 ± 0.3[66]
Brain glioma cells (intracellular)4.5 ± 0.5 
Skin1.1–4.6[66, 67]
Liver5.4 ± 0.7[66, 68]
Liver (mitochondrial)3-4[69]
Skeletal muscle3.8 ± 0.2[70]
Skeletal muscle (intracellular)3.4–4.8Lanza et al. 2010
Kidney9.5 ± 2.6[66]
Kidney (intracellular)6.6–7.9[71]
Bone marrow1.3–2[72, 73]

O2 participates in many metabolic reactions, some of which are sensitive to O2 levels in the range between physioxia and 18%. Therefore, mammalian cells should be cultured in physiologically relevant O2 levels. Where this is not done, it is important to be aware of the potential consequences on cellular functions. One potential consequence of elevated O2 in cell culture media is increased cellular production of reactive oxygen (ROS) and nitrogen (RNS) species. This probably contributes to the observed effects of high O2 levels on cell senescence, differentiation, and apoptosis, amongst a wide range of other less well-characterized effects ([46]; Fehrer et al. 2007).

There is a growing appreciation of the role of O2 levels in cell biology (e.g., [7, 8]). However, there is a limited mechanistic understanding of how supraphysiological O2 levels influence specific O2-dependent processes. In this review, we consider the O2 sensitivity of some of the important O2-consuming organelles and enzymes in mammalian cells in the range between physioxia and 18% O2 (standard cell culture conditions). We use the Michaelis-Menten constant (Km(O2)) for each O2-consuming enzyme (where this value is available) as a convenient way to compare O2 sensitivity across a broad range of different organelles and enzymes. All O2 and Km(O2) values from published works have been converted to % O2 at 37°C, since % O2 is the unit of measurement used in most descriptions of cell culture experiments. In general, higher Km(O2) values are indicative of enzymes that will be more sensitive to the differences between in vivo and in vitro O2 levels. We address the physiological role(s) of the metabolite(s) produced from these O2-consuming reactions and the O2 sensitivity over the range from physiological to 18% O2 of that reaction. We further summarize the interesting observation that many of the O2-consuming and ROS/RNS-producing enzymes are positively regulated by hypoxia, in some instances specifically by hypoxia-inducible factor-1 (HIF-1).

1.1. Oxygen Limitation of Mitochondrial Respiration in Cell Culture

An important goal of maintaining higher O2 levels in culture is to ensure that mitochondrial respiration is not limited by O2 availability. Some of the most comprehensive and physiologically relevant data on the O2 levels required to sustain maximal mitochondrial respiration rates have been provided by Hoffmann et al. (2009), who measured these values for isolated liver mitochondria while systematically varying O2 concentrations. State 4 respiration of complex I or complex II substrates (glutamate/malate or succinate, respectively) or of palmitoyl carnitine is near maximal at ~1% O2 (Hoffman 2009). Marcinek et al. (2003) showed that respiration in skeletal muscle is not O2 limited until O2 falls below ~0.5%, which is similar to the observation by Gnaiger (2001) for isolated rat liver mitochondria. To understand how this relates to O2 sufficiency in cell culture, we can compare these values to the levels of O2 present in media immediately outside of cells (pericellular O2) or within the cytosol (Table 2).


Cell line and conditionsExtracellular O2 (%)Intracellular O2 (%)References

Confluent, differentiated PC12 cell monolayer20~15[74]
10~7
6~1.5
HeLa20~17[75]
108-9
52–5
Undifferentiated PC12 cells20~15[76]
81-2
Mouse embryonic fibroblasts206–8[76]
Mouse embryonic fibroblasts20~14[9]
92-3
5~0.5

Pericellular O2 values for adherent cell monolayers can be measured in real time using a variety of approaches, including Luxcel and Seahorse platforms (Agilent, USA). We use PreSens OxyDish (PreSens Precision Sensing GMBH, Germany) which has O2-sensitive fluorescent probes impregnated into the tissue culture dish plastic. For most cell lines seeded at typical densities and maintained in a 5% CO2 incubator at 37°C without O2 control, headspace O2~18% and pericellular O2 levels are close to this [3]. This is far in excess of what is needed to support maximal mitochondrial respiration rates. When headspace O2 is maintained at more physiologically relevant levels, however, pericellular and intracellular O2 levels may become significantly lower, particularly if media changes and/or mixing are infrequent.

Intracellular O2 levels can be measured in cultured cells using a variety of fluorescent probes (Zhdanov et al. 2012; [9]). Measurements using these tools show that, at the higher levels of O2 (~20%) typical of standard cell culture, intracellular O2 levels range from 14–17% depending upon cell type, medium composition (specifically whether fuel source promotes reliance on oxidative phosphorylation), and seeding density (Table 2). Conditions promoting faster rates of O2 consumption lower these values, but they are generally hyperoxic regardless. At more physiologically relevant headspace O2 levels of 5–9%, intracellular O2 levels under typical culture conditions range from 0.5% to 5%. Thus, under standard cell culture conditions, intracellular O2 levels are typically at least 10 times higher than what is required to sustain maximal mitochondrial respiration rates based on the Vmax values reported by Hoffman et al. (2009) and others. On the other hand, cell culture at 5-6% headspace O2 results in intracellular O2 levels that may be low enough to limit respiration when cells are at high density or growing in respiration-promoting media.

Although a higher than physiological headspace O2 level in tissue culture helps to ensure that mitochondrial respiration is not oxygen limited, it may have the unintended consequence of stimulating the production of ROS and RNS from various enzymes that are widely expressed in common cell lines. Increases in ROS/RNS with concomitant effects on redox-sensitive signaling events and potentially oxidative macromolecular damage should be expected under these conditions, and indeed, these are observed. It is therefore important to understand the relationship between oxygen levels and the rates of ROS/RNS production in cultured cells. In mammalian cells, ROS/RNS are produced by a wide range of organelles and enzymes, including mitochondria, NADPH oxidase (Nox), nitric oxide synthase (NOS), monoamine oxidase (MAO), xanthine oxidase/oxidoreductase (XO/XOR), lipoxygenase (LOX), cyclooxygenase (COX), heme oxygenase (HOX), and the transplasma membrane redox system (tPMRS). Here, we discuss how the hyperoxia of standard cell culture is expected to affect the activities and/or expression of all these organelles and enzymes. Our list of oxygen-dependent enzymes is not exhaustive, and we have omitted some oxygen-metabolizing enzymes for which we could not readily find data regarding oxygen sensitivity of reaction rates.

1.2. Oxygen Concentration and Mitochondrial ROS Production

Superoxide/H2O2 production as a byproduct of oxidative phosphorylation has been well studied in isolated mitochondria, and many sites of production, albeit under generally nonphysiological conditions, have been identified (Figure 1). The specific sites of mitochondrial superoxide production have been reviewed recently (e.g., [10]) and will not be detailed here. Superoxide produced at various sites within mitochondria is released into either the matrix or the IMS side of the inner membrane. H2O2 arising from superoxide within the mitochondrial matrix can diffuse out of the matrix.

Although mitochondria are often stated to be responsible for the majority of cellular ROS production, this has not been demonstrated [11] and indeed seems unlikely to be universally true given that the total cell volume occupied by mitochondria varies from a few percent in low-metabolic rate cells to as much as 30% in cardiomyocytes [12]. Similarly, the relative levels of other ROS and RNS producers like Nox and NOS vary greatly between cell types and physiological condition. Therefore, while it may be true that mitochondria are the most important sites of ROS production in some cell types, they may not be in others. Nonetheless, it is important to consider the sensitivity of mitochondrial ROS production to the oxygen levels prevailing in cells in culture.

Hoffman et al. (2007; 2009) provided detailed measurements and calculations of H2O2 production (originating as superoxide) from isolated liver mitochondria respiring in state 4 on various substrates at 37°C (Table 3). Measurements were made over a range of O2 levels, with and without various respiratory poisons, allowing the calculation of Km(O2) values for H2O2 production associated with different respiratory substrates and ETC sites. Notably, of the sites contributing to mitochondrial H2O2 production in cultured cells, which is likely primarily the complex I FMN site and the complex III Qo site, both are saturated at the same low O2 levels as respiration. Note that ETFQOR is probably not a major contributor to mitochondrial H2O2 production under standard cell culture conditions because fatty acids are not included as fuels in most commercial media. The physiological relevance of complex I backflow is established only in ischemia/reperfusion [13], and these would be expected to occur in normal cell culture only as hypoxia-hyperoxia transitions during media changes or passaging. Therefore, based on the above observations, the rate of mitochondrial ROS production is likely not O2-limited under most standard cell culture conditions or at headspace O2 levels as low as 5%, providing that intracellular O2 remains above 0.5%. Thus, little difference is expected in mitochondrial ROS production between 5% (physioxia) and 18% (standard cell culture) O2.


SubstratesKm(O2) (%)H2O2 production (pmol min−1·mg protein−1)

Glutamate + malate with malonate0.025250
Succinate (− rotenone)0.179330
Succinate (+ rotenone)0.070105
Glutamate, malate, and succinate0.050330
Palmitoylcarnitine (− rotenone)0.100290
Palmitoylcarnitine (+ rotenone)0.398250

Sites
Complex III Qo site0.199150
Complex I FMN site0.019170
Complex I electron backflow0.090135
ETFQOR0.498200

All values are from Hoffman et al. 2009 and measured using an Amplex Red/horseradish peroxidase assay in the presence of superoxide dismutase at 37°C.
1.3. NADPH Oxidases

There are seven members of the family of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (Nox1–5 and Duox 1 and 2), several of which (e.g., Nox1, 2, and 4) are quite widely distributed amongst mammalian tissues and cell lines [14]. Noxs are multisubunit membrane-spanning enzymes that transport electrons from NAD(P)H across biological membranes [15]. Although the Nox enzymes localize to a variety of cellular membranes, all can be found in the plasma membrane, where they transport electrons to external O2, thus leading to the production of superoxide in the extracellular space [14]. Superoxide produced outside the cell and dismuted to H2O2 can diffuse back into the cell of origin or into neighbouring cells.

Importantly, recent work indicates that Nox4 differs from other Nox isoforms in several important ways. Firstly, Nox4 localizes (at least in some cells and/or some physiological conditions) to mitochondria [16] where its activity appears to interact with respiratory complex I and ATP [17, 18]. Nox4 activity is not dependent upon interactions with accessory subunits. Furthermore, Nox4 preferentially produces H2O2 rather than superoxide [19]. The rate of Nox4 H2O2 production is also very sensitive to O2 levels in the range between physioxia and 18%.

There is surprisingly little Km(O2) data for any of the Nox isoforms. Furthermore, there is some doubt regarding the validity of some assays of Nox activity using isolated membrane fractions [20, 21]. Nonetheless, the available data suggest that the activities of Nox1, Nox2, and Nox4 are all sensitive to O2 levels in the range from 5% to 18% (Table 4). Nox4, with a Km(O2) value~18%, is particularly sensitive over this range; Nox4 activity triples between 3% and 12% O2 [19]. Direct measurements with cultured PC3 and C2C12 cells indicate a substantial contribution of Nox1 and/or Nox4 to H2O2 production in live cells (measured as Amplex Red oxidation), particularly at 18% O2, since this value is strongly inhibited by GKT138731 (a Nox1/4 inhibitor; Figure 2). Similarly, in Nox1/2/4 triple knockout mouse dermal fibroblasts, H2O2 production at 18% O2 is only about 1/10 to that in wild-type fibroblasts, and, at 5% O2, H2O2 production is undetectable (Figure 2). Thus, although somewhat limited, available evidence indicates that Nox isoforms produce H2O2 at rates that are strongly dependent upon O2 levels. This probably underlies observations such as the Nox4 contribution to cellular senescence in primary cell lines, since these studies have been performed at 18% O2. Whether Nox4 plays the same roles in vivo, where O2 levels are several times lower, is not clear but must be considered.


EnzymeProductKm(O2) (%)DetailsReference

Nox2O23.5[77]
Nox2O23.1[78]
Nox2O22-3[19]
Nox2O22-3[79]
Nox4H2O218[78]
Nox4H2O218[19]
Nox4H2O216–20[79]
nNOSNO2.3Purified bovine enzyme[45]
nNOSNO/O22.2Partially uncoupled rat enzyme[42, 43]
O23.4Fully uncoupled rat enzyme
nNOSNO15.7Purified rat enzyme[47]
nNOSNO39.8Purified rat enzyme[80]
nNOSNO28.5Kinetic model based on rat enzyme data[81, 82]
eNOSNO0.8Purified bovine enzyme[45]
eNOSNO0.3Kinetic model based on rat enzyme data[82, 83]
iNOSNO0.63 ± 0.09Purified bovine enzyme[45]
iNOSNO11.0Isolated enzyme assay[84]
iNOSNO10.6Kinetic model[82]
NOSNO3.1–10.8Unspecified isoform[48, 85]
XOO2·−/H2O22.2–6.8Isolated from bovine milkFridovich et al. 1962, 1964
MAOH2O23.4–28Mammalian enzymes; various substrates[8688]; reviewed in [57]
HOCO, iron, and bilirubin<1.5Unspecified isoform from chicken liver[59]
LOXH2O21–2.6Unspecified isoform[65]
COX-1Various0.4–3.1Arachidonic acid substrate[63, 8991]
COX-2Various1.3–1.5Arachidonic acid substrate[63, 65]
PHDModified HIF41–46Various substrates[92]
FIHModified HIF4–12Various substrates[92]

Nox: NADPH oxidase; NOS: nitric oxide synthase; XO: xanthine oxidase; MAO: monoamine oxidase; HO: heme oxygenase; LOX: lipoxygenase; COX: cyclooxygenase; PHD: prolyl hydroxylase; FIH: factor inhibiting HIF-1.
1.4. Transplasma Membrane Redox System

The transplasma membrane electron transfer (tPMET) system is a ubiquitous system for transferring electrons from cytosolic NAD(P)H outside of the cell, similar to the Noxs [22]. The core components of the tPMET system are the NAD(P)H-quinone oxidoreductase (NQO1), NADH-cytochrome b5 reductase (CytB5red), coenzyme Q10, and the ecto-NADH oxidase disulfide thiol exchanger (ENox). Both NQO1 and CytB5red are distributed in multiple intracellular localizations, including in association with the plasma membrane.

The tPMET system makes significant contributions to cellular O2 consumption in many common cell lines (e.g., Jurkat, RAW264.7, and pancreatic beta cells; see [23, 24]). The tPMET system is highly upregulated in respiration-deficient (ρ0) cells, which accumulate coenzyme Q10 in the plasma membrane [25]. In ρ0 cells, the tPMRS may be the predominant site of O2 consumption [24].

A variety of extracellular terminal electron acceptors are possible, including O2, which can undergo single-electron reduction to produce superoxide. Purified mammalian CytB5red produces superoxide directly [26], though its overexpression has beneficial effects in some specific contexts [27, 28]. NQO1 is associated with an intracellular antioxidant function (e.g., [29]) but contributes to reduction of extracellular electron acceptors, presumably including O2, in pancreatic beta cells [23]. ENox proteins include several isoforms—the age-related arNox may be the most relevant in terms of ROS production in cell culture. This isoform produces superoxide and becomes more highly expressed in the tissues of aged mammals and in late-passage or senescent cells in culture [30].

The tPMET system has only been measured under standard cell culture O2 (18%), and we are not aware of any data regarding the sensitivity of superoxide production to O2 concentration for the system as a whole or for individual components of the system. Nonetheless, consideration should be given to the possibility that the tPMRS is O2 sensitive in the 5–18% range and that O2-dependent changes in its activity could affect cell physiology.

1.5. Role of Aquaporins in Transmembrane H2O2 and Gas Diffusion

The tPMRS and all Nox isoforms (a portion of all Nox isoforms localizes to the plasma membrane) can produce either superoxide or H2O2 on the extracellular side of the plasma membrane. Here, these ROS may react with membranes or membrane-bound proteins facing the extracellular space on the originating cell or on neighbouring cells. Alternatively, H2O2, either directly produced or resulting from superoxide dismutation, may cross cell membranes to exert intracellular effects. The H2O2 permeability of phospholipid bilayers is limited; indeed, H2O2 is less membrane permeant than H2O [31]. However, H2O2 rapidly equilibrates across cell membranes via aquaporins (AQPs). Structural studies suggest that all water-transporting AQPs may facilitate some degree of H2O2 movement across cellular membranes [32]. However, empirical data is less equivocal, suggesting that hAQP3 and hAQP8 are particularly good H2O2 transporters [31].

Interestingly, O2 levels modulate the expression of several AQPs. AQP1 and AQP3 mRNA and protein levels are both increased at 1% versus 20% O2 ([33]; Hoogewijs et al. 2016), though AQP5 and AQP9 expressions are reduced at lower O2 levels ([34]; Castro-Parodi et al. 2013). There is also some evidence that hypoxia can affect AQP8 permeability directly via posttranslational modifications [35]. Recent studies ([36]; Zwiazek et al. 2017) also suggest that some AQP isoforms facilitate the transport of O2 and therefore may facilitate O2 uptake by cells at low O2 levels. There is also strong evidence that AQP1 and AQP4 can transport other important ROS/RNS, such as NO [37, 38]. Taken together, these observations indicate that media O2 levels are likely to modulate the H2O2, NO, and O2 permeability of cell membranes via their effects on AQP expression and/or activity. This makes it more difficult to understand the detailed kinetics of how ROS/RNS and gases traverse cellular membranes in vivo when measurements are done in vitro under nonphysiological O2 conditions.

1.6. Nitric Oxide Synthases

NOS are a family of enzymes responsible for the production of NO and L-citrulline from L-arginine and O2 [39, 40]. Three isoforms of NOS have been identified: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) [41]. These three NOS isoforms share approximately 50% amino acid identity [41], and all three are widely expressed in mammalian tissues and cell lines. Under some conditions, including transient anoxia/reoxygenation, NOS catalyzes an “uncoupled” reaction producing superoxide instead of NO (Stuehr et al. 1991; [42, 43]; reviewed in [44]).

The first detailed study of the O2 sensitivity of the NOS reaction was by Rengasamy and Johns [45] who calculated a Km(O2) value of 0.63 to 2.31% O2 for NOS isolated from bovine brain and aortic endothelium as well as RAW 264.7 mouse macrophages. Subsequently, Km(O2) values have been published for various tissues and cell lines, as well as for specific purified NOS isoforms (Table 4). Although these values vary widely, presumably due to differences in experimental conditions, O2 affinities of nNOS and iNOS are found relatively consistently to be within a range that is sensitive to changes in O2 levels between physioxia and 18% O2. Cell lines with high levels of these two isoforms will therefore produce more NO under standard cell culture conditions than in vivo. Cell culture models of ischemia/reperfusion injury typically employ a period of near anoxia followed by return to “normoxia” where the latter is 18% O2. NOS activity can be uncoupled under these conditions, and the rate of superoxide production upon reoxygenation at 18% O2 likely exceeds that which would occur upon a return to physioxia in vivo.

NO can also be produced by the reduction of nitrite catalyzed by several enzymes including XO/XOR [46]. This reaction is promoted at lower O2 levels and makes it difficult to predict the effect of O2 levels on NO production rates. Thus, the relationship between cellular NO synthesis rates and O2 levels will depend on the relative abundance of different NOS isoforms, which have different sensitivities to O2.

In addition to its effects on NO synthesis, O2 levels influence NO metabolism ([47, 48]; reviewed in [49]). NO is metabolized in cells by poorly characterized pathways. However, it is known that the rate of NO metabolism by cells is faster at higher O2 levels [50]. Thus, higher O2 levels will affect the rate of NO production from nNOS and iNOS while simultaneously increasing the rate of their metabolism. Again, it is difficult to predict how this will affect steady-state NO levels in all cells. In activated RAW 264.7 cells in culture, the maximum rates of NO production were observed at 8% O2 [50], though the relationship between O2 and NO levels in other cell types is unknown. The O2-dependent rate of NO metabolism will in turn affect its diffusional distance and therefore alter the subset of proteins modified in the cell of origin or neighbouring cells. NO participates in many regulatory posttranslational modifications of key proteins, including those driving epigenetic modifications. Given these diverse influences of NO on cellular functions and the effects of O2 levels on synthesis, diffusion distance, and metabolism of NO, there is clear potential to generate nonphysiologically relevant results at nonphysiological O2 levels.

1.7. Other Oxidases

XO and MAO are two widely expressed cellular oxidases whose products include superoxide and H2O2. XO and its precursor XOR are expressed in mammalian cells, where they localize to the cytosol and the external face of the plasma membrane [51]. Both XO and XOR can catalyze the oxidation of purines, producing superoxide radical and H2O2 [52]. Under some conditions, XO may also catalyze NO production from nitrites and nitrates, a reaction that is favoured at lower O2 [46]. However, the levels of these latter compounds are relatively low in culture media and this activity may therefore be of minor importance in mammalian cell culture. The Km(O2) value of bovine XO has been reported in the range of 3–6% O2 (Table 4). Interestingly, the relative production of superoxide versus H2O2 by XO is also sensitive to O2 levels within the range found in cell culture (1–21%), such that at O2 levels below 5% O2, H2O2 formation is promoted [53]. In addition, high O2 levels promote posttranslational modifications of XOR that decrease its specific activity [54, 55]. Thus, O2 levels in culture could affect the relative rates of ROS production by XO/XOR as well as the relative amounts of superoxide versus H2O2 produced.

MAO occurs as two isoforms, MAO-A and MAO-B. Both are widely distributed in mammalian tissues [56]. They localize to the outer mitochondrial membrane where they catalyze the degradation of biogenic and dietary monoamines such as norepinephrine, dopamine, tyramine, serotonin, phenylethylamine, and benzylamine in a reaction producing H2O2. The reported Km(O2) values of both isoforms vary widely (Table 4) due to a complicated reaction mechanism in which O2 affinity is strongly affected by monoamine concentrations (reviewed in [57]). MAO enzyme activities are nonetheless predicted to be sensitive to O2 over the range of 5–18%. Because the H2O2 produced by MAOs is near the mitochondrial compartment, aberrant mitochondrial and cytosolic redox signaling and/or macromolecular damage may be caused by MAO enzymes in the O2 conditions typical of standard cell culture.

1.8. Oxygenases

Oxygenases catalyze the incorporation of oxygen into an organic substrate. Heme oxygenase (HOX), lipoxygenase (LOX), and cyclooxygenase (COX) are all widely expressed in mammalian tissues and cell lines. HOX is important in the process of heme degradation, while both COX and LOX assist in the breakdown of arachidonic acid via two separate pathways.

HOX is localized in the endoplasmic reticulum (reviewed in [58]). There are two isoforms, HOX-1 and HOX-2, sharing an amino acid sequence identity of >45%. While HOX-2 is constitutively expressed, HOX-1 is induced by endogenous and exogenous stressors such as heavy metals, pharmacological agents, inflammatory mediators, UV light, and oxidative stress. HOX enzymes oxidize heme to produce carbon monoxide, Fe2+, and biliverdin. HOX purified from chicken liver has maximal activity at O2 levels as low as 1.5% ([59]; Table 4), indicating that this enzyme is likely O2 saturated even in cells cultured in physioxia.

COX is a dioxygenase that catalyzes the first step of arachidonic acid or linoleic acid breakdown leading to the production of prostanoid derivatives (reviewed in [60]). COX enzymes modulate cell growth and signaling pathways and are implicated in cancer progression [61]. There are two isoforms, COX-1 and COX-2, with an amino acid sequence homology of ~60%. COX enzymes localize to the endoplasmic reticulum membrane and nuclear envelope. These enzymes catalyze two-step reactions. In the first step, cyclooxygenase activity using molecular oxygen produces the hydroperoxide prostaglandin G2 intermediate. Peroxidase activity is then observed resulting in the formation of prostaglandin H2. The Km(O2) value of COX-1-catalyzed arachidonic acid oxidation varies between 0.4% and 3.1% O2, while the Km(O2) value of COX-2 is somewhat lower (Table 4). Activities of COX-1 and COX-2 saturate at around 10–20% O2 [62, 63]. Thus, these enzymes are also O2 sensitive in the range of interest, and as their products modulate various cellular activities including cell growth and differentiation [61], it is possible that their increased activities at 18% O2 affect studies of cell physiology in culture.

LOX catalyzes the deoxygenation of polyunsaturated fatty acids, producing a variety of oxygen and lipid radicals under some conditions (reviewed in [60]). There are six isoforms of LOX that are widely distributed in mammalian tissues and cells. LOX enzymes produce ROS and lipid radical species that participate in intracellular signaling pathways. O2 levels affect the lipoxygenase reaction in complex ways [64, 65], but the measured Km(O2) values are 1–2.6% O2 (Table 4), making reaction rates O2 sensitive in the relevant range.

1.9. Transcriptional Regulation of ROS/RNS-Producing Enzymes

In addition to acute effects on the activities of enzyme-catalyzed reactions, O2 levels in cell culture may affect the expression of various O2-consuming enzymes and organelles. HIF-1 and HIF-2 are heterodimeric transcription factors whose activities are regulated by O2 via the degradation of the α-subunits (HIF-1α, HIF-2α). This reaction is catalyzed by prolyl hydroxylase (PHD), which uses O2 and 2-oxoglutarate to hydroxylate the HIF-α subunits leading to their subsequent ubiquitination and degradation. A second reaction, hydroxylation of an asparagine in HIF-1α catalyzed by the factor inhibiting HIF-1 (FIH), inhibits HIF-1 transcriptional activity. Together, O2 regulates the levels and activity of HIF-1 and/or HIF-2. Both hydroxylation reactions are O2 sensitive within the physioxia to 18% O2 range. Mammalian PHD isoforms have a Km(O2) value~25% O2 and FIH Km(O2) value~11% (Table 4). In addition, PHD activities may be modulated by ROS/RNS produced by many of the enzymes discussed above at higher rates under standard culture conditions.

Hundreds of genes are transcriptionally regulated by HIFs, and interestingly, most of the ROS/RNS-producing enzymes discussed above are amongst them. In our experiments, the relative levels of Nox1 and Nox4 are much higher at 5% compared to 18% O2 (Figure 3). Indeed, Nox4, all three NOS isoforms, LOX, COX, MAO, and HOX are all transcriptional targets of HIFs (Table 5). In addition, several AQPs are HIF regulated, indicating that the H2O2 permeability of cellular membranes is likely different at physioxia versus 18% O2. It is important to note that virtually, all data regarding the HIF regulation of these enzymes has been collected using 18% O2 as “normoxia” and 1% O2 as hypoxia but similar results are expected for 5% versus 18% comparison.


EnzymeEffectReference

Nox1Transcriptional stimulation by HIF-1Goyal et al. 2004
Nox4Transcriptional stimulation[93]
nNOSTranscriptional stimulation[94]
eNOSTranscriptional stimulation[95]
Stabilization of mRNA[96]
iNOSTranscriptional stimulation by HIF-1[9799]
XOTranscriptional stimulation[54]
MAOTranscriptional stimulation[100]
HOTranscriptional stimulation[101]
LOXTranscriptional stimulation[102]
COXTranscriptional stimulationDemasi et al. 2004;
AQP1Transcriptional stimulation[103]
AQP3Transcriptional stimulationHoogewijs et al. 2016
AQP5Transcriptional repression[34]
AQP9Unclear mechanismCastro-Parodi et al. 2013

Nox: NADPH oxidase; NOS: nitric oxide synthase; XO: xanthine oxidase; MAO: monoamine oxidase; HO: heme oxygenase; LOX: lipoxygenase; COX: cyclooxygenase; AQP: aquaporin.

In terms of the impact on cell culture experiments, the effects of O2 on the specific activities (based on Km(O2) values) versus levels of O2-consuming proteins (based on transcriptional upregulation) would tend to oppose each other, though our measurement of higher rates of cellular ROS production at 18% O2 versus 5% O2 suggests that they do not cancel. It is unclear to what extent the combined effects of media O2 on acute metabolic flux through the various O2-consuming pathways and the transcriptional regulation via HIF-1/2 activation of their component proteins, would impact cell physiology. Indeed, it seems impossible to predict how the hyperoxia of cell culture will impact the numerous O2-sensitive, O2-consuming, metabolic reactions overall given these concomitant changes in specific activity and expression.

1.10. Conclusions

Under standard cell culture conditions, media O2 levels of typically~18% are hyperoxic with respect to the 1–6% experienced by most mammalian cells in vivo (Table 1). This disparity has important consequences for the accurate modeling of in vivo cell physiology, so it is important to have a comprehensive understanding of how O2 affects specific ROS/RNS-producing processes. Although rates of ROS production from mitochondrial respiration are relatively insensitive to increases in O2 levels from 5% to 18% O2, many widespread O2-consuming cellular enzymes are very sensitive in this same range. In particular, the activities of Nox4, nNOS, eNOS, and both MAO isoforms appear to be strongly induced at higher O2 levels. These enzymes will thus produce substantially more ROS/RNS, potentially affecting the states of intracellular signaling pathways and the downstream events they are regulating. This is unlikely to be an appropriate starting point upon which to impose further stresses and expect a “normal” physiological response that mimics an in vivo context.

In addition to acute effects of O2 on flux through specific metabolic pathways, there is evidence that chronic exposure to the hyperoxia of cell culture will also affect the expression of Nox, NOS, MAO, and other O2-consuming enzymes (Table 5). Presumably, this is a homeostatic mechanism for tuning these reactions to O2 availability. However, it again establishes a baseline condition that may not accurately model the in vivo state. Even the permeability of cellular membranes to H2O2, NO, or O2 may be influenced by O2-mediated transcriptional regulation of AQPs, given their role in facilitating the diffusion of these molecules (Table 5).

The specific effects of O2 on cellular ROS/RNS production described above point to the importance of culturing cells at physiologically relevant O2 levels. In most cases, this requires lowering the incubator headspace O2 levels. However, this can cause pericellular and intracellular hypoxia, depending upon cell density and mitochondrial respiration rates. Therefore, it is further necessary to monitor pericellular O2 levels and take steps to maintain them within a physiologically relevant range. We have found that standing O2 gradients from the top of the media column to the pericellular region are present in undisturbed cell culture and that regular gentle mixing (e.g., via a rocker plate) can abolish these. Our simple solution to this problem will be presented in a future publication.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

References

  1. E. O. Pettersen, L. H. Larsen, N. B. Ramsing, and P. Ebbesen, “Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors,” Cell Proliferation, vol. 38, no. 4, pp. 257–267, 2005. View at: Publisher Site | Google Scholar
  2. R. H. Wenger, V. Kurtcuoglu, C. C. Scholz, H. H. Marti, and D. Hoogewijs, “Frequently asked questions in hypoxia research,” Hypoxia, vol. 3, pp. 35–43, 2015. View at: Publisher Site | Google Scholar
  3. L. A. Maddalena, S. M. Selim, J. Fonseca, H. Messner, S. McGowan, and J. A. Stuart, “Hydrogen peroxide production is affected by oxygen levels in mammalian cell culture,” Biochemical and Biophysical Research Communications, vol. 493, no. 1, pp. 246–251, 2017. View at: Publisher Site | Google Scholar
  4. M. Zscharnack, C. Poesel, J. Galle, and A. Bader, “Low oxygen expansion improves subsequent chondrogenesis of ovine bone-marrow-derived mesenchymal stem cells in collagen type I hydrogel,” Cells Tissues Organs, vol. 190, no. 2, pp. 81–93, 2009. View at: Publisher Site | Google Scholar
  5. J. Milosevic, S. C. Schwarz, K. Krohn, M. Poppe, A. Storch, and J. Schwarz, “Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors,” Journal of Neurochemistry, vol. 92, no. 4, pp. 718–729, 2005. View at: Publisher Site | Google Scholar
  6. V. Renault, L. E. Thornell, G. Butler-Browne, and V. Mouly, “Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock,” Experimental Gerontology, vol. 37, no. 10-11, pp. 1229–1236, 2002. View at: Publisher Site | Google Scholar
  7. M. Weiszenstein, N. Pavlikova, M. Elkalaf et al., “The effect of pericellular oxygen levels on proteomic profile and lipogenesis in 3T3-L1 differentiated preadipocytes cultured on gas-permeable cultureware,” PLoS One, vol. 11, no. 3, p. e0152382, 2016. View at: Publisher Site | Google Scholar
  8. N. Haque, M. T. Rahman, N. H. Abu Kasim, and A. M. Alabsi, “Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy,” The Scientific World Journal, vol. 2013, Article ID 632972, 12 pages, 2013. View at: Publisher Site | Google Scholar
  9. R. I. Dmitriev, A. V. Zhdanov, G. Jasionek, and D. B. Papkovsky, “Assessment of cellular oxygen gradients with a panel of phosphorescent oxygen-sensitive probes,” Analytical Chemistry, vol. 84, no. 6, pp. 2930–2938, 2012. View at: Publisher Site | Google Scholar
  10. H. S. Wong, P. A. Dighe, V. Mezera, P. A. Monternier, and M. D. Brand, “Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions,” Journal of Biological Chemistry, vol. 292, no. 41, pp. 16804–16809, 2017. View at: Publisher Site | Google Scholar
  11. G. C. Brown and V. Borutaite, “There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells,” Mitochondrion, vol. 12, no. 1, pp. 1–14, 2012. View at: Publisher Site | Google Scholar
  12. J. A. Stuart, L. A. Maddalena, M. Merilovich, and E. L. Robb, “A midlife crisis for the mitochondrial free radical theory of aging,” Longevity & Healthspan, vol. 3, no. 1, p. 4, 2014. View at: Publisher Site | Google Scholar
  13. E. T. Chouchani, V. R. Pell, E. Gaude et al., “Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS,” Nature, vol. 515, no. 7527, pp. 431–435, 2014. View at: Publisher Site | Google Scholar
  14. A. Panday, M. K. Sahoo, D. Osorio, and S. Batra, “NADPH oxidases: an overview from structure to innate immunity-associated pathologies,” Cellular & Molecular Immunology, vol. 12, no. 1, pp. 5–23, 2015. View at: Publisher Site | Google Scholar
  15. K. Bedard and K.-H. Krause, “The Nox family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at: Publisher Site | Google Scholar
  16. K. Block, Y. Gorin, and H. E. Abboud, “Subcellular localization of Nox4 and regulation in diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14385–14390, 2009. View at: Publisher Site | Google Scholar
  17. K. Shanmugasundaram, B. K. Nayak, W. E. Friedrichs, D. Kaushik, R. Rodriguez, and K. Block, “NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance,” Nature Communications, vol. 8, no. 1, p. 997, 2017. View at: Publisher Site | Google Scholar
  18. R. Koziel, H. Pircher, M. Kratochwil et al., “Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4,” Biochemical Journal, vol. 452, no. 2, pp. 231–239, 2013. View at: Publisher Site | Google Scholar
  19. Y. Nisimoto, B. A. Diebold, D. Cosentino-Gomes, and J. D. Lambeth, “Nox4: a hydrogen peroxide-generating oxygen sensor,” Biochemistry, vol. 53, no. 31, pp. 5111–5120, 2014. View at: Publisher Site | Google Scholar
  20. F. Rezende, O. Lowe, V. Helfinger et al., “Unchanged NADPH oxidase activity in Nox1-Nox2-Nox4 triple knockout mice: what do NADPH-stimulated chemiluminescence assays really detect?” Antioxidants & Redox Signaling, vol. 24, no. 7, pp. 392–399, 2016. View at: Publisher Site | Google Scholar
  21. F. Rezende, K.-K. Prior, O. Lowe et al., “Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays,” Free Radical Biology & Medicine, vol. 102, pp. 57–66, 2017. View at: Publisher Site | Google Scholar
  22. P. Navas, J. M. Villalba, and R. de Cabo, “The importance of plasma membrane coenzyme Q in aging and stress responses,” Mitochondrion, vol. 7, pp. S34–S40, 2007. View at: Publisher Site | Google Scholar
  23. J. P. Gray, T. Eisen, G. W. Cline, P. J. S. Smith, and E. Heart, “Plasma membrane electron transport in pancreatic β-cells is mediated in part by NQO1,” American Journal of Physiology-Endocrinology and Metabolism, vol. 301, no. 1, pp. E113–E121, 2011. View at: Publisher Site | Google Scholar
  24. P. M. Herst and M. V. Berridge, “Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1767, no. 2, pp. 170–177, 2007. View at: Publisher Site | Google Scholar
  25. C. Gómez-Díaz, J. M. Villalba, R. Pérez-Vicente, F. L. Crane, and P. Navas, “Ascorbate stabilization is stimulated in ρ°HL-60 cells by CoQ10increase at the plasma membrane,” Biochemical and Biophysical Research Communications, vol. 234, no. 1, pp. 79–81, 1997. View at: Publisher Site | Google Scholar
  26. A. K. Samhan-Arias and C. Gutierrez-Merino, “Purified NADH-cytochrome b5 reductase is a novel superoxide anion source inhibited by apocynin: sensitivity to nitric oxide and peroxynitrite,” Free Radical Biology & Medicine, vol. 73, pp. 174–189, 2014. View at: Publisher Site | Google Scholar
  27. D.-H. Hyun and G.-H. Lee, “Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics,” Age, vol. 37, no. 6, p. 122, 2015. View at: Publisher Site | Google Scholar
  28. A. Martin-Montalvo, Y. Sun, A. Diaz-Ruiz et al., “Cytochrome b5 reductase and the control of lipid metabolism and healthspan,” npj Aging and Mechanisms of Disease, vol. 2, no. 1, article 16006, 2016. View at: Publisher Site | Google Scholar
  29. D.-H. Hyun, S. S. Emerson, D.-G. Jo, M. P. Mattson, and R. de Cabo, “Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 52, pp. 19908–19912, 2006. View at: Publisher Site | Google Scholar
  30. D. James Morré and D. M. Morré, Ecot-Nox Proteins: Growth, Cancer, and Aging, Springer Press, New York, NY, USA, 2013.
  31. G. P. Bienert and F. Chaumont, “Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 5, pp. 1596–1604, 2014. View at: Publisher Site | Google Scholar
  32. A. Almasalmeh, D. Krenc, B. Wu, and E. Beitz, “Structural determinants of the hydrogen peroxide permeability of aquaporins,” The FEBS Journal, vol. 281, no. 3, pp. 647–656, 2014. View at: Publisher Site | Google Scholar
  33. I. Abreu-Rodriguez, R. Sanchez Silva, A. P. Martins et al., “Functional and transcriptional induction of aquaporin-1 gene by hypoxia; analysis of promoter and role of HIF-1α,” PLoS One, vol. 6, no. 12, article e28385, 2011. View at: Publisher Site | Google Scholar
  34. J. D. Kawedia, F. Yang, M. A. Sartor, D. Gozal, M. Czyzyk-Krzeska, and A. G. Menon, “Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways,” PLoS One, vol. 8, no. 3, article e57541, 2013. View at: Publisher Site | Google Scholar
  35. I. Medrano-Fernandez, S. Bestetti, M. Bertolotti et al., “Stress regulates aquaporin-8 permeability to impact cell growth and survival,” Antioxidants & Redox Signaling, vol. 24, no. 18, pp. 1031–1044, 2016. View at: Publisher Site | Google Scholar
  36. Y. Wang and E. Tajkhorshid, “Nitric oxide conduction by the brain aquaporin AQP4,” Proteins: Structure, Function, and Bioinformatics, vol. 78, no. 3, pp. 661–670, 2010. View at: Publisher Site | Google Scholar
  37. M. Herrera and J. L. Garvin, “Aquaporins as gas channels,” Pflügers Archiv - European Journal of Physiology, vol. 462, no. 4, pp. 623–630, 2011. View at: Publisher Site | Google Scholar
  38. R. D. Fontijn, O. L. Volger, T. C. van der Pouw-Kraan et al., “Expression of nitric oxide-transporting aquaporin-1 is controlled by KLF2 and marks non-activated endothelium in vivo,” PLoS One, vol. 10, no. 12, article e0145777, 2015. View at: Publisher Site | Google Scholar
  39. O. W. Griffith and D. J. Stuehr, “Nitric oxide synthases: properties and catalytic mechanism,” Annual Review of Physiology, vol. 57, no. 1, pp. 707–734, 1995. View at: Publisher Site | Google Scholar
  40. M. A. Marletta, “Nitric oxide synthase structure and mechanism,” Journal of Biological Chemistry, vol. 268, no. 17, pp. 12231–12234, 1993. View at: Google Scholar
  41. W. K. Alderton, C. E. Cooper, and R. G. Knowles, “Nitric oxide synthases: structure, function and inhibition,” Biochemical Journal, vol. 357, no. 3, pp. 593–615, 2001. View at: Publisher Site | Google Scholar
  42. Y. T. Gao, S. P. Panda, L. J. Roman, P. Martásek, Y. Ishimura, and B. S. S. Masters, “Oxygen metabolism by neuronal nitric-oxide synthase,” Journal of Biological Chemistry, vol. 282, no. 11, pp. 7921–7929, 2007. View at: Publisher Site | Google Scholar
  43. Y. T. Gao, L. J. Roman, P. Martásek, S. P. Panda, Y. Ishimura, and B. S. S. Masters, “Oxygen metabolism by endothelial nitric-oxide synthase,” Journal of Biological Chemistry, vol. 282, no. 39, pp. 28557–28565, 2007. View at: Publisher Site | Google Scholar
  44. N. D. Roe and J. Ren, “Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases,” Vascular Pharmacology, vol. 57, no. 5-6, pp. 168–172, 2012. View at: Publisher Site | Google Scholar
  45. A. Rengasamy and R. A. Johns, “Determination of Km for oxygen of nitric oxide synthase isoforms,” Journal of Pharmacology and Experimental Therapeutics, vol. 276, no. 1, pp. 30–33, 1996. View at: Google Scholar
  46. N. Cantu-Medellin and E. E. Kelley, “Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: Insights regarding where, when and how,” Nitric Oxide, vol. 34, pp. 19–26, 2013. View at: Publisher Site | Google Scholar
  47. I. M. Elayan, M. J. Axley, P. V. Prasad, S. T. Ahlers, and C. R. Auker, “Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain,” Journal of Neurophysiology, vol. 83, no. 4, pp. 2022–2029, 2000. View at: Publisher Site | Google Scholar
  48. C. C. McCormick, W. P. Li, and M. Calero, “Oxygen tension limits nitric oxide synthesis by activated macrophages,” Biochemical Journal, vol. 350, no. 3, pp. 709–716, 2000. View at: Publisher Site | Google Scholar
  49. D. D. Thomas, “Breathing new life into nitric oxide signaling: a brief overview of the interplay between oxygen and nitric oxide,” Redox Biology, vol. 5, pp. 225–233, 2015. View at: Publisher Site | Google Scholar
  50. J. R. Hickok, D. Vasudevan, K. Jablonski, and D. D. Thomas, “Oxygen dependence of nitric oxide-mediated signaling,” Redox Biology, vol. 1, no. 1, pp. 203–209, 2013. View at: Publisher Site | Google Scholar
  51. M. G. Battelli, L. Polito, M. Bortolotti, and A. Bolognesi, “Xanthine oxidoreductase-derived reactive species: physiological and pathological effects,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3527579, 8 pages, 2016. View at: Publisher Site | Google Scholar
  52. N. Cantu-Medellin and E. E. Kelley, “Xanthine oxidoreductase-catalyzed reactive species generation: a process in critical need of reevaluation,” Redox Biology, vol. 1, no. 1, pp. 353–358, 2013. View at: Publisher Site | Google Scholar
  53. E. E. Kelley, N. K. H. Khoo, N. J. Hundley, U. Z. Malik, B. A. Freeman, and M. M. Tarpey, “Hydrogen peroxide is the major oxidant product of xanthine oxidase,” Free Radical Biology & Medicine, vol. 48, no. 4, pp. 493–498, 2010. View at: Publisher Site | Google Scholar
  54. E. E. Kelley, T. Hock, N. K. H. Khoo et al., “Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells,” Free Radical Biology and Medicine, vol. 40, no. 6, pp. 952–959, 2006. View at: Publisher Site | Google Scholar
  55. N. Linder, E. Martelin, R. Lapatto, and K. O. Raivio, “Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions,” American Journal of Physiology-Cell Physiology, vol. 285, no. 1, pp. C48–C55, 2003. View at: Publisher Site | Google Scholar
  56. D. E. Edmondson, “Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications,” Current Pharmaceutical Design, vol. 20, no. 2, pp. 155–160, 2014. View at: Publisher Site | Google Scholar
  57. K. F. Tipton, “90 years of monoamine oxidase: some progress and some confusion,” Journal of Neural Transmission, pp. 1–33, 2018. View at: Publisher Site | Google Scholar
  58. J. Munoz-Sanchez and M. E. Chanez-Cardenas, “A review on hemeoxygenase-2: focus on cellular protection and oxygen response,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 604981, 16 pages, 2014. View at: Publisher Site | Google Scholar
  59. H. L. Bonkovsky, J. F. Healey, and J. Pohl, “Purification and characterization of heme oxygenase from chick liver: comparison of the avian and mammalian enzymes,” European Journal of Biochemistry, vol. 189, no. 1, pp. 155–166, 1990. View at: Publisher Site | Google Scholar
  60. C. Schneider, D. A. Pratt, N. A. Porter, and A. R. Brash, “Control of oxygenation in lipoxygenase and cyclooxygenase catalysis,” Chemistry & Biology, vol. 14, no. 5, pp. 473–488, 2007. View at: Publisher Site | Google Scholar
  61. C. Sobolewski, C. Cerella, M. Dicato, L. Ghibelli, and M. Diederich, “The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies,” International Journal of Cell Biology, vol. 2010, Article ID 215158, 21 pages, 2010. View at: Publisher Site | Google Scholar
  62. Y. Liu and J. P. Roth, “A revised mechanism for human cyclooxygenase-2,” Journal of Biological Chemistry, vol. 291, no. 2, pp. 948–958, 2016. View at: Publisher Site | Google Scholar
  63. J. Qiao, L. Ma, J. Roth, Y. Li, and Y. Liu, “Kinetic basis for the activation of human cyclooxygenase-2 rather than cyclooxygenase-1 by nitric oxide,” Organic & Biomolecular Chemistry, vol. 16, no. 5, pp. 765–770, 2018. View at: Publisher Site | Google Scholar
  64. I. Ivanov, J. Saam, H. Kuhn, and H.-G. Holzhutter, “Dual role of oxygen during lipoxygenase reactions,” The FEBS Journal, vol. 272, no. 10, pp. 2523–2535, 2005. View at: Publisher Site | Google Scholar
  65. I. Juránek, H. Suzuki, and S. Yamamoto, “Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1436, no. 3, pp. 509–518, 1999. View at: Publisher Site | Google Scholar
  66. A. Carreau, B. E. Hafny-Rahbi, A. Matejuk, C. Grillon, and C. Kieda, “Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia,” Journal of Cellular and Molecular Medicine, vol. 15, no. 6, pp. 1239–1253, 2011. View at: Publisher Site | Google Scholar
  67. W. Wang, C. P. Winlove, and C. C. Michel, “Oxygen partial pressure in outer layers of skin of human finger nail folds,” The Journal of Physiology, vol. 549, no. 3, pp. 855–863, 2003. View at: Publisher Site | Google Scholar
  68. A. J. Brooks, J. Eastwood, I. J. Beckingham, and K. J. Girling, “Liver tissue partial pressure of oxygen and carbon dioxide during partial hepatectomy,” British Journal of Anaesthesia, vol. 92, no. 5, pp. 735–737, 2004. View at: Publisher Site | Google Scholar
  69. E. G. Mik, T. Johannes, C. J. Zuurbier et al., “In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique,” Biophysical Journal, vol. 95, no. 8, pp. 3977–3990, 2008. View at: Publisher Site | Google Scholar
  70. R. S. Richardson, S. Duteil, C. Wary, D. W. Wray, J. Hoff, and P. G. Carlier, “Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability,” The Journal of Physiology, vol. 571, no. 2, pp. 415–424, 2006. View at: Publisher Site | Google Scholar
  71. Y. Hirakawa, T. Yoshihara, M. Kamiya et al., “Quantitating intracellular oxygen tension in vivo by phosphorescence lifetime measurement,” Scientific Reports, vol. 5, no. 1, article 17838, 2015. View at: Publisher Site | Google Scholar
  72. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan et al., “Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1,” Nature Medicine, vol. 10, no. 8, pp. 858–864, 2004. View at: Publisher Site | Google Scholar
  73. J. A. Spencer, F. Ferraro, E. Roussakis et al., “Direct measurement of local oxygen concentration in the bone marrow of live animals,” Nature, vol. 508, no. 7495, pp. 269–273, 2014. View at: Publisher Site | Google Scholar
  74. A. V. Zhdanov, V. I. Ogurtsov, C. T. Taylor, and D. B. Papkovsky, “Monitoring of cell oxygenation and responses to metabolic stimulation by intracellular oxygen sensing technique,” Integrative Biology, vol. 2, no. 9, pp. 443–451, 2010. View at: Publisher Site | Google Scholar
  75. H. Düssmann, S. Perez-Alvarez, U. Anilkumar, D. B. Papkovsky, and J. H. M. Prehn, “Single-cell time-lapse imaging of intracellular O2 in response to metabolic inhibition and mitochondrial cytochrome-c release,” Cell Death & Disease, vol. 8, no. 6, article e2853, 2017. View at: Publisher Site | Google Scholar
  76. R. I. Dmitriev and D. B. Papkovsky, “Optical probes and techniques for O2 measurement in live cells and tissue,” Cellular and Molecular Life Sciences, vol. 69, no. 12, pp. 2025–2039, 2012. View at: Publisher Site | Google Scholar
  77. G. T. Gabig, I. S. Bearman, and M. B. Babior, “Effects of oxygen tension and pH on the respiratory burst of human neutrophils,” Blood, vol. 53, pp. 1133–1139, 1979. View at: Google Scholar
  78. R. P. Brandes, N. Weissmann, and K. Schröder, “Nox family NADPH oxidases: molecular mechanisms of activation,” Free Radical Biology & Medicine, vol. 76, pp. 208–226, 2014. View at: Publisher Site | Google Scholar
  79. S. Guo and X. Chen, “The human nox4: gene, structure, physiological function and pathological significance,” Journal of Drug Targeting, vol. 23, no. 10, pp. 888–896, 2015. View at: Publisher Site | Google Scholar
  80. H. M. Abu-Soud, D. L. Rousseau, and D. J. Stuehr, “Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension,” Journal of Biological Chemistry, vol. 271, no. 51, pp. 32515–32518, 1996. View at: Publisher Site | Google Scholar
  81. H. M. Abu-Soud, J. Wang, D. L. Rousseau, J. M. Fukuto, L. J. Ignarro, and D. J. Stuehr, “Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis,” Journal of Biological Chemistry, vol. 270, no. 39, pp. 22997–23006, 1995. View at: Publisher Site | Google Scholar
  82. J. Santolini, A. L. Meade, and D. J. Stuehr, “Differences in three kinetic parameters underpin the unique catalytic profiles of nitric-oxide synthases I, II, and III,” Journal of Biological Chemistry, vol. 276, no. 52, pp. 48887–48898, 2001. View at: Publisher Site | Google Scholar
  83. H. M. Abu-Soud, K. Ichimori, A. Presta, and D. J. Stuehr, “Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase,” Journal of Biological Chemistry, vol. 275, no. 23, pp. 17349–17357, 2000. View at: Publisher Site | Google Scholar
  84. R. A. Dweik, D. Laskowski, H. M. Abu-Soud et al., “Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism,” The Journal of Clinical Investigation, vol. 101, no. 3, pp. 660–666, 1998. View at: Publisher Site | Google Scholar
  85. M. A. Robinson, J. E. Baumgardner, V. P. Good, and C. M. Otto, “Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages,” American Journal of Physiology-Cell Physiology, vol. 294, no. 4, pp. C1079–C1087, 2008. View at: Publisher Site | Google Scholar
  86. M. D. Houslay and K. F. Tipton, “Rat liver mitochondrial monoamine oxidase. A change in the reaction mechanism on solubilization,” Biochemical Journal, vol. 145, no. 2, pp. 311–321, 1975. View at: Publisher Site | Google Scholar
  87. M. Husain, D. E. Edmondson, and T. P. Singer, “Kinetic studies on the catalytic mechanism of liver monoamine oxidase,” Biochemistry, vol. 21, no. 3, pp. 595–600, 1982. View at: Publisher Site | Google Scholar
  88. D. P. Jones, “Benzylamine metabolism at low O2 concentrations: relative sensitivities of monoamine oxidase, aldehyde dehydrogenase and hippurate synthesis to hypoxia,” Biochemical Pharmacology, vol. 33, no. 3, pp. 413–417, 1984. View at: Publisher Site | Google Scholar
  89. W. E. M. Lands, J. Sauter, and G. W. Stone, “Oxygen requirement for prostaglandin biosynthesis,” Prostaglandins and Medicine, vol. 1, no. 2, pp. 117–120, 1978. View at: Publisher Site | Google Scholar
  90. A. Mukherjee, D. W. Brinkley, K.-M. Chang, and J. P. Roth, “Molecular oxygen dependent steps in fatty acid oxidation by cyclooxygenase-1,” Biochemistry, vol. 46, no. 13, pp. 3975–3989, 2007. View at: Publisher Site | Google Scholar
  91. O. A. Ponomareva, N. A. Trushkin, I. S. Filimonov et al., “Prostaglandin H synthase kinetics in the two-phase aqueous-micellar system,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1858, no. 9, pp. 2199–2207, 2016. View at: Publisher Site | Google Scholar
  92. H. Tarhonskaya, A. P. Hardy, E. A. Howe et al., “Kinetic investigations of the role of factor inhibiting hypoxia-inducible factor (FIH) as an oxygen sensor,” Journal of Biological Chemistry, vol. 290, no. 32, pp. 19726–19742, 2015. View at: Publisher Site | Google Scholar
  93. I. Diebold, A. Petry, J. Hess, and A. Gorlach, “The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1,” Molecular Biology of the Cell, vol. 21, no. 12, pp. 2087–2096, 2010. View at: Publisher Site | Google Scholar
  94. S. A. Saravanaperumal, J. H. Lee, S. A. Syed et al., “Hypoxia-inducible factor 1 alpha (HIF1A) stimulates neuronal nitric oxide synthase (NOS1) transcription by binding to multiple enhancers,” Gastroenterology, vol. 152, no. 5, pp. S565–S566, 2017. View at: Publisher Site | Google Scholar
  95. F. Coulet, S. Nadaud, M. Agrapart, and F. Soubrier, “Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter,” Journal of Biological Chemistry, vol. 278, no. 47, pp. 46230–46240, 2003. View at: Publisher Site | Google Scholar
  96. L. Kalinowski, A. Janaszak-Jasiecka, A. Siekierzycka et al., “Posttranscriptional and transcriptional regulation of endothelial nitric-oxide synthase during hypoxia: the role of microRNAs,” Cellular & Molecular Biology Letters, vol. 21, no. 1, p. 16, 2016. View at: Publisher Site | Google Scholar
  97. G. Melillo, T. Musso, A. Sica, L. S. Taylor, G. W. Cox, and L. Varesio, “A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 1683–1693, 1995. View at: Publisher Site | Google Scholar
  98. F. Jung, L. A. Palmer, N. Zhou, and R. A. Johns, “Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes,” Circulation Research, vol. 86, no. 3, pp. 319–325, 2000. View at: Publisher Site | Google Scholar
  99. R. Hu, A. Dai, and S. Tan, “Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hypoxic rat,” Chinese Medical Journal, vol. 115, no. 12, pp. 1833–1837, 2002. View at: Google Scholar
  100. M. A. Sharpe and D. S. Baskin, “Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HIF-1α and with transcription factors Sp1 and Sp3,” Oncotarget, vol. 7, no. 3, pp. 3379–3393, 2016. View at: Publisher Site | Google Scholar
  101. P. J. Lee, B.-H. Jiang, B. Y. Chin et al., “Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia,” Journal of Biological Chemistry, vol. 272, no. 9, pp. 5375–5381, 1997. View at: Publisher Site | Google Scholar
  102. C. S. Gonsalves and V. K. Kalra, “Hypoxia-mediated expression of 5-lipoxygenase–activating protein involves HIF-1α and NF-κB and microRNAs 135a and 199a-5p,” The Journal of Immunology, vol. 184, no. 7, pp. 3878–3888, 2010. View at: Publisher Site | Google Scholar
  103. L. Tie, N. Lu, X.-Y. Pan et al., “Hypoxia-induced up-regulation of aquaporin-1 protein in prostate cancer cells in a p38-dependent manner,” Cellular Physiology and Biochemistry, vol. 29, no. 1-2, pp. 269–280, 2012. View at: Publisher Site | Google Scholar

Copyright © 2018 Jeffrey A. Stuart et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

7388 Views | 1472 Downloads | 8 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.